The UK regulators have stated that 30 cases of rare blood clot events have been reported following the use of the AstraZeneca COVID-19 vaccine.

The Medicines and Healthcare products Regulatory Agency added that there were no such reports of clotting events after use of the Pfizer-BioNTech COVID-19 vaccine. The health officials maintained that the benefits of the vaccine in preventing COVID-19 still outweigh any possible blood clot risk.

While some countries have restricted the use of AstraZeneca vaccine, others have resumed its use, amid investigations into the reports of rare blood clot events.

The regulator had stated on March 18 that five cases of a rare brain blood clot had been reported among 11 million administered vaccine doses. On Thursday, it made it as 22 reports of cerebral venous sinus thrombosis, and 8 reports of other clotting events associated with low blood platelets from among 18.1 million doses administered… (Reuters, April 2, 2021)